Schadt Eric
- SEC CIK
- 0001873468
No open-market purchases or sales filed in the past year.
Current role at each company
- WGS GeneDx Holdings Corp.President & Chief R&D Officeras of May 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schadt Eric as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2022 (view filing) | May 20 | 4 days | Schadt EricPresident & Chief R&D Officer | PPurchaseClass A Common Stock | +100.0K | $1.92 | +$192.0K | +69.7%243.4K after | |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Schadt EricPresident & Chief R&D Officer | SSaleClass A Common Stock | −35.9K | $2.18 | −$78.3K | −20.0%143.4K after | |
| Feb 2, 2022 (view filing) | Jan 28 | 5 daysLate | Schadt EricChief Executive Officer | SSaleClass A Common Stock | −29.1K | $2.84 | −$82.6K | −22.5%100.5K after | |
| Nov 2, 2021 (view filing) | Oct 25 | 8 daysLate | Schadt EricChief Executive Officer | SSaleClass A Common Stock | −33.3K | $7.54 | −$251.3K | −42.3%45.5K after |